Agios Pharmaceuticals, Inc.

38 Sidney Street
2nd Floor
Cambridge
Massachusetts
02139-4169
United States

Tel: 617-649-8600

Show jobs for this employer

About Agios Pharmaceuticals, Inc.


Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic metabolic disorders through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has multiple first-in-class investigational medicines in clinical and/or preclinical development. All Agios programs focus on genetically identified patient populations, leveraging our knowledge of metabolism, biology and genomics. For more information, please visit the company's website at www.agios.com.

YEAR FOUNDED:

August 7, 2007

LEADERSHIP:

Founders: Lewis Cantley, Tak Mak, Craig Thompson, Shin-San Michael Su

CEO: David Schenkein

CMO (Medical): Chris Bowden

CSO (Scientific): Scott Biller

JOBS:

Please click here for Agios job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.

202 articles with Agios Pharmaceuticals, Inc.